Clearmind Medicine (CMND) vs PMGC (ELAB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Clearmind Medicine is the larger company by market cap ($1.3 million vs $1.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CMND | ELAB |
|---|---|---|
| Share price | $2.63 | $1.14 |
| Market cap | $1.33M | $1.33M |
| 1-day change | -17.68% | -10.24% |
| EPS (TTM) | $-461.20 | $-555.60 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $590.08K |
| Net income (latest FY) | $-3.86M | $-7.75M |
| Gross margin | — | 31.40% |
| Net margin | — | -1313.00% |
| 52-week high | $649.60 | $1,344.00 |
| 52-week low | $2.63 | $1.14 |
| Distance from 52-week high | -99.60% | -99.92% |
| Average volume | 55.57K | 279.01K |
| Shares outstanding | 507.40K | 1.17M |
| Employees | — | 32 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Clearmind Medicine
CMND stock →Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression.
Health Care · Biotechnology: Pharmaceutical Preparations
About PMGC
ELAB stock →PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining.
Health Care · Biotechnology: Pharmaceutical Preparations · 32 employees
CMND vs ELAB FAQ
Which is bigger, Clearmind Medicine or PMGC?
Clearmind Medicine (CMND) is larger, with a market capitalization of $1.33M compared with $1.33M for PMGC (ELAB).
Are Clearmind Medicine and PMGC in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.